Inventor · disambiguated record
Lingshu Wang
Also filed as: WANG LINGSHU
9 granted patents·7 pending applications·45 citations·filing 2016–2025
85Inventor score
Files withUS HEALTH5ABCELLERA BIOLOGICS INC3ABCELLERA BIOLOGIES INC2MODEX THERAPEUTICS INC2THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES2
Top patents by PatentIndex Score
16 records- 0196US10301377B2Middle east respiratory syndrome coronavirus immunogens, antibodies, and their useUS HEALTH·Filed 2016·Granted May 28, 2019·24 cites·23 claims
- 0293US11793871B2Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereofUS HEALTH·Filed 2022·Granted Oct 24, 2023·2 cites·18 claims
- 0392US11370828B2Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGIES INC·Filed 2021·Granted Jun 28, 2022·9 cites·30 claims
- 0491US11447541B1Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGIES INC·Filed 2021·Granted Sep 20, 2022·3 cites·26 claims
- 0590US11338033B2Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereofTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted May 24, 2022·5 cites·15 claims
- 0676US12172038B2Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGICS INC·Filed 2023·Granted Dec 24, 2024·0 cites·25 claims
- 0773US10898566B2Zika virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Jan 26, 2021·2 cites·20 claims
- 0868US12077572B2Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereofUS HEALTH·Filed 2022·Granted Sep 3, 2024·0 cites·9 claims
- 0964US2022356229A1Anti-Coronavirus Antibodies and Methods of UseABCELLERA BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 1063US2021292393A1Anti-Coronavirus Antibodies and Methods of UseABCELLERA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 1160US10759846B2Middle east respiratory syndrome coronavirus immunogens, antibodies, and their useUS HEALTH·Filed 2019·Granted Sep 1, 2020·0 cites·26 claims
- 1260US2025000968A1Sars-cov-2 spike fused to a hepatitis b surface antigenTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2022·Application pending·0 cites
- 1360US2024109955A1Anti-sars-cov-2 antigen binding polypeptides, polypeptide complexes and methods of use thereofMODEX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1455US2024117011A1Antibodies targeting the spike protein of coronavirusesUS HEALTH·Filed 2022·Application pending·0 cites
- 1547US2025326823A1Antigen Binding Polypeptides, Polypeptide Complexes and Methods of Use ThereofMODEX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1641US2021355193A1Monoclonal anitbody for spike protein of middle east respiratory syndrome coronavirus and use thereofKOREA CENTER DISEASE CONTROL & PREVENTION·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lingshu Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →